Preparing for an FDA BIMO Inspection: A Sponsor’s Reality
What sponsors should expect during a BIMO inspection, how to prepare effectively, and where most organizations fall short.
A sponsor BIMO inspection is a distinctly different experience from a clinical investigator (site) inspection. While site inspections focus heavily on source data and patient safety at a granular level, a sponsor inspection is an evaluation of systemic control. The FDA is assessing whether the sponsor maintained a firm grip on the execution of the entire trial.
The Vendor Oversight Trap
The most frequent point of failure for sponsors is vendor oversight. Contracting a highly reputable CRO does not absolve the sponsor of responsibility. During an inspection, the investigator will demand to see the transfer of obligations, the vendor oversight plan, and critically, the objective evidence that the sponsor actually executed that plan.
If a CRO monitor failed to identify a significant protocol deviation at a site, the FDA will ask the sponsor: "Why didn't your oversight mechanisms catch the monitor's failure?" Preparing for a sponsor inspection requires ensuring that the narrative of your oversight is clearly documented, defensible, and continuously active throughout the life of the trial.
End of File
Return to Top arrow_upward